# Sideris Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sideris-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.siderispharma.com
- Total disclosed funding: $32M
- Latest round: Series A (Oct 22, 2013)
- Investors on record: 3

## About

Sideris Pharmaceuticals is based in the United States and operates as an independent biopharmaceutical company focused on the development of treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy.

## Funding rounds

- Series A, Oct 22, 2013, $32M — Hatteras Venture Partners, OUP (Osage University Partners), MPM BioImpact

## Investors

- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series A
- OUP (Osage University Partners) (https://capitalatlas.ai/funds/oup-osage-university-partners) — Series A
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A